632 related articles for article (PubMed ID: 19501602)
21. 5-HT(2A) and 5-HT(2C) receptor stimulation are differentially involved in the cortical dopamine efflux-Studied in 5-HT(2A) and 5-HT(2C) genetic mutant mice.
Huang M; Dai J; Meltzer HY
Eur J Pharmacol; 2011 Feb; 652(1-3):40-5. PubMed ID: 21118683
[TBL] [Abstract][Full Text] [Related]
22. Serotonin 1B and 2C receptor interactions in the modulation of feeding behaviour in the mouse.
Dalton GL; Lee MD; Kennett GA; Dourish CT; Clifton PG
Psychopharmacology (Berl); 2006 Mar; 185(1):45-57. PubMed ID: 16470405
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity in rats.
Vickers SP; Benwell KR; Porter RH; Bickerdike MJ; Kennett GA; Dourish CT
Br J Pharmacol; 2000 Jul; 130(6):1305-14. PubMed ID: 10903970
[TBL] [Abstract][Full Text] [Related]
24. Selective serotonin receptor stimulation of the medial nucleus accumbens causes differential effects on food intake and locomotion.
Pratt WE; Blackstone K; Connolly ME; Skelly MJ
Behav Neurosci; 2009 Oct; 123(5):1046-57. PubMed ID: 19824770
[TBL] [Abstract][Full Text] [Related]
25. Serotonin 2C receptor agonists and the behavioural satiety sequence in mice.
Hewitt KN; Lee MD; Dourish CT; Clifton PG
Pharmacol Biochem Behav; 2002 Apr; 71(4):691-700. PubMed ID: 11888560
[TBL] [Abstract][Full Text] [Related]
26. Neuroimaging and 5-HT2C receptor polymorphism: a HMPAO-SPECT study in healthy male probands using mCPP-challenge of the 5-HT2C receptor.
Kühn KU; Joe AY; Meyer K; Reichmann K; Maier W; Rao ML; Reinhardt MJ; Biersack HJ; Quednow BB
Pharmacopsychiatry; 2004 Nov; 37(6):286-91. PubMed ID: 15551195
[TBL] [Abstract][Full Text] [Related]
27. Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats.
Hayes DJ; Mosher TM; Greenshaw AJ
Behav Brain Res; 2009 Feb; 197(2):323-30. PubMed ID: 18805442
[TBL] [Abstract][Full Text] [Related]
28. 5-HT2C receptor mediation of unconditioned escape behaviour in the unstable elevated exposed plus maze.
Jones N; Duxon MS; King SM
Psychopharmacology (Berl); 2002 Nov; 164(2):214-20. PubMed ID: 12404085
[TBL] [Abstract][Full Text] [Related]
29. Effects of mu-CPP and mesulergine on dietary choices in deprived rats: possible mechanisms of their action.
Antonatos S; Galanopoulou P
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):112-9. PubMed ID: 16242827
[TBL] [Abstract][Full Text] [Related]
30. Role of 5-HT3 and 5-HT2C receptors located within the medial amygdala in the control of salt intake in sodium-depleted rats.
Luz C; Souza A; Reis R; Fregoneze JB; de Castro e Silva E
Brain Res; 2006 Jul; 1099(1):121-32. PubMed ID: 16765332
[TBL] [Abstract][Full Text] [Related]
31. Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors.
Cryan JF; Lucki I
J Pharmacol Exp Ther; 2000 Dec; 295(3):1120-6. PubMed ID: 11082448
[TBL] [Abstract][Full Text] [Related]
32. Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols.
Cussac D; Newman-Tancredi A; Quentric Y; Carpentier N; Poissonnet G; Parmentier JG; Goldstein S; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):242-52. PubMed ID: 11882920
[TBL] [Abstract][Full Text] [Related]
33. Selective activation of 5-HT(2C) receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study.
Invernizzi RW; Pierucci M; Calcagno E; Di Giovanni G; Di Matteo V; Benigno A; Esposito E
Neuroscience; 2007 Feb; 144(4):1523-35. PubMed ID: 17161544
[TBL] [Abstract][Full Text] [Related]
34. Role of the 5-HT2C receptor in improving weight-supported stepping in adult rats spinalized as neonates.
Kao T; Shumsky JS; Jacob-Vadakot S; Himes BT; Murray M; Moxon KA
Brain Res; 2006 Sep; 1112(1):159-68. PubMed ID: 16914121
[TBL] [Abstract][Full Text] [Related]
35. Prospects for serotonin 5-HT2R pharmacotherapy in psychostimulant abuse.
Bubar MJ; Cunningham KA
Prog Brain Res; 2008; 172():319-46. PubMed ID: 18772040
[TBL] [Abstract][Full Text] [Related]
36. Validation of a selective serotonin 5-HT(2C) receptor antibody for utilization in fluorescence immunohistochemistry studies.
Bubar MJ; Seitz PK; Thomas ML; Cunningham KA
Brain Res; 2005 Nov; 1063(2):105-13. PubMed ID: 16274677
[TBL] [Abstract][Full Text] [Related]
37. Thermogenic effect of YM348, a novel 5-HT2C-receptor agonist, in rats.
Hayashi A; Suzuki M; Sasamata M; Miyata K
J Pharm Pharmacol; 2004 Dec; 56(12):1551-6. PubMed ID: 15563762
[TBL] [Abstract][Full Text] [Related]
38. Partial 5-HT(1A) receptor agonist activity by the 5-HT(2C) receptor antagonist SB 206,553 is revealed in rats spinalized as neonates.
Shumsky JS; Kao T; Amato N; Simansky K; Murray M; Moxon KA
Exp Neurol; 2005 Feb; 191(2):361-5. PubMed ID: 15649492
[TBL] [Abstract][Full Text] [Related]
39. Identification of 4-methyl-1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles as 5-HT2C receptor agonists.
Röver S; Adams DR; Bénardeau A; Bentley JM; Bickerdike MJ; Bourson A; Cliffe IA; Coassolo P; Davidson JE; Dourish CT; Hebeisen P; Kennett GA; Knight AR; Malcolm CS; Mattei P; Misra A; Mizrahi J; Muller M; Porter RH; Richter H; Taylor S; Vickers SP
Bioorg Med Chem Lett; 2005 Aug; 15(15):3604-8. PubMed ID: 15975787
[TBL] [Abstract][Full Text] [Related]
40. Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment.
Zaniewska M; McCreary AC; Wydra K; Filip M
Synapse; 2010 Jul; 64(7):511-9. PubMed ID: 20196140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
